Oxygenta Pharmaceutical Ltd
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 |
|---|---|---|---|
| Revenue | 49.79 | 33.93 | 14.25 |
| Operating Expense | 49.50 | 38.01 | 18.88 |
| Net Profit | -1.70 | -4.84 | -4.93 |
| Net Profit Margin | -3.41% | -14.26% | -34.60% |
| Earning Per Share | -0.45 | -1.32 | -1.33 |
| EBIDTA | -0.13 | -2.59 | -3.12 |
| Effective Tax Rate | 0% | -0% | -0% |
Particulars
Mar 2026
Revenue49.79
Operating Expense49.50
Net Profit-1.70
Net Profit Margin-3.41
Earning Per Share-0.45
EBIDTA-0.13
Effective Tax Rate0
